SCHEMBL14720733

SCHEMBL14720733

O=CCN1C2CCC1CC(O)(c1ccc(C=C3CCN(C4CCC4)CC3)cc1)C2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 11/20 0.35
DRD4 P21917 6/20 0.35
DRD3 P35462 6/20 0.35
USP2 O75604 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 1/20 0.35
NPBWR1 P48145 1/20 0.35
MCHR1 Q99705 1/20 0.35
OPRM1 P35372 1/20 0.33
OPRL1 P41146 1/20 0.33
HTR1A P08908 6/20 0.33
HTR2A P28223 6/20 0.33
HRH1 P35367 6/20 0.33
HTR2C P28335 2/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
ADRA1A P35348 1/20 0.33
ADRA1B P35368 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720732 0.82 CYP2C19 (0.41) DRD2DRD4ALDH1A1MAPK1MCHR1
SCHEMBL14721332 0.79 HRH3 (0.39) OPRM1OPRL1HRH3SRD5A2
SCHEMBL14720774 0.78 HRH3 (0.40) OPRM1OPRL1HRH3SRD5A2
SCHEMBL14720812 0.78 HRH3 (0.34) OPRM1OPRL1HRH3SRD5A2
SCHEMBL14720457 0.77 HRH3 (0.33) USP2ALDH1A1MAPK1MCHR1OPRM1
SCHEMBL14720765 0.76 KMT2A (0.38) ALDH1A1POLB
SCHEMBL14721633 0.76 HRH3 (0.36) OPRM1OPRL1HRH3
SCHEMBL14731091 0.76 OPRM1 (0.35) OPRM1OPRL1HRH3SRD5A2
SCHEMBL14720746 0.75 HRH3 (0.38) OPRL1HRH3
SCHEMBL14720865 0.74 HRH3 (0.35) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed